Clinical Trial Update: Dose-Exposure-Response in Type 1 Diabetes Mellitus [Phase 1]

View source ↗

Summary

Sanofi completed a Phase 1 study evaluating dose-exposure-response in Type 1 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type I | Phase 1 | Status: COMPLETED